Insulin

|

33

Colorado Becomes First State to Limit the Price of Insulin

Colorado became the first state in the nation to pass legislation combating the increasing price of insulin. The prices, for some, are so high they …

|

Special Spotlight On Diabetes Insulins: Invokana (canagliflozin)

Medically reviewed by Zara Risoldi Cochrane, PharmD, MS, FASCP on April 24, 2019 — Written by Victor Nguyen, PharmD, MS. Republished with …

Eli Lilly and Company’s Lower-Priced Insulin Now Available

Eli Lilly and Company announced its generic, half-priced version of Humalog insulin is now available for order in pharmacies across the U.S. The …

Special Spotlight on Diabetes Insulins: Farxiga (dapagliflozin)

Medically reviewed by Lindsay Slowiczek, PharmD. 11/18. Republished with permission from Healthline. In a special partnership, dLife is proud to …

New “Pill” That Can Deliver Insulin Could Replace Injections for Patients with Type 2 Diabetes

An MIT-led research team has developed a drug capsule that could be used to deliver oral doses of insulin, potentially replacing the injections that …

|

Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs

By: Emmarie Huetteman and Rachel Bluth, Kaiser Health News Senators railed against pharmaceutical executives last Tuesday for declining to testify …

|

Sky-rocketing Insulin Prices Prompt New Movement Across the U.S.

More than 7 million Americans are insulin dependent. And recent findings show that 1-in-4 Americans are rationing their insulin, a dangerous way …

| | |

Study Predicts Worldwide Insulin Shortage by the Year 2030

With the number of people with diabetes growing worldwide, a new study finds there will be a shortage of insulin by the year 2030, mainly due to …

Endocrine Society Urges More Transparency to Combat Soaring Insulin Costs

Out-of-control insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. According to …

|

Big 3 Insulin Makers Receive Lawsuit For “Deceptive” Price Hikes

Minnesota Attorney General Lori Swanson is the latest to file a lawsuit against the nation’s three largest insulin makers, Sanofi-Aventis U.S. …

|